IVA
- Inventiva S.A.
()
Overview
Company Summary
Inventiva S.A. is a company that operates in the biopharmaceutical industry. The company specializes in the discovery and development of drugs to treat various diseases with significant unmet medical needs, particularly in the field of fibrosis, oncology, and rare genetic diseases.
Inventiva focuses on the development of small molecules, which are chemical compounds designed to interact with specific proteins or targets in the body to provide therapeutic benefits. The company's research and development efforts aim to identify and deliver innovative treatments that address the underlying mechanisms of these diseases, thereby offering improved outcomes for patients.
The company follows a comprehensive drug development approach, which includes target validation, lead optimization, preclinical testing, as well as clinical trials in humans. Inventiva strategically combines its in-house expertise with external collaborations and partnerships to accelerate the development and commercialization of its drug candidates.
Inventiva has a diversified pipeline of drug candidates at different stages of development. The company's most advanced product candidate, called lanifibranor, is being developed to treat multiple fibrotic diseases, such as non-alcoholic steatohepatitis (NASH), systemic sclerosis, and liver fibrosis.
Overall, Inventiva S.A. is focused on harnessing scientific innovation to discover and develop novel therapies that can potentially bring significant benefits to patients suffering from debilitating diseases with limited treatment options.